CapsoVision (CV) Free Cash Flow (2024 - 2025)
CapsoVision's (CV) quarterly Free Cash Flow came in at -$7.7 million in Q4 2025, down 42.51% year-on-year from -$13.4 million in Q4 2024, and down 35.51% quarter-over-quarter from -$5.7 million in Q3 2025.
CapsoVision (CV) Free Cash Flow (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Free Cash Flow across 2 years of filings, most recently posting -$7.7 million for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$7.7 million, down 42.51% year-over-year; the trailing twelve-month figure through Dec 2025 was -$18.8 million (changed N/A YoY), and the FY2025 annual result was -$23.0 million, down 13.39% from the prior year.
- Free Cash Flow came in at -$7.7 million for Q4 2025 at CapsoVision, down from -$5.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.4 million in Q4 2024 to a low of -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | -7.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.69 Mn |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | -5.68 Mn |
| Sep 30, 2025 | -5.68 Mn |
| Dec 31, 2024 | -5.40 Mn |
| Dec 31, 2024 | -5.40 Mn |
| Sep 30, 2024 | -7.06 Mn |
| Sep 30, 2024 | -7.06 Mn |